Lenzing Target price 2025 - Analyst rating & recommendation
Lenzing Classifications & Recommendation:
Lenzing Price Target
| Target Price | €30.60 |
| Price | €26.50 |
| Potential | 15.47% |
| Number of Estimates | 6 |
| 6 Analysts have issued a price target Lenzing 2026 . The average Lenzing target price is €30.60. This is 15.47% higher than the current stock price. The highest price target is €35.70 34.72% , the lowest is €20.20 23.77% . | |
| A rating was issued by 11 analysts: 0 Analysts recommend Lenzing to buy, 6 to hold and 5 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Lenzing stock has an average upside potential 2026 of 15.47% . Most analysts recommend the Lenzing stock at Hold. |
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion € | 2.66 | 2.71 |
| 5.66% | 1.69% | |
| EBITDA Margin | 4.54% | 16.59% |
| 25.11% | 265.72% |
6 Analysts have issued a sales forecast Lenzing 2025 . The average Lenzing sales estimate is €2.7b . This is 0.55% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €2.9b 6.82% , the lowest is €2.6b 4.54% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | €2.7b | 5.66% |
|---|---|---|
| 2025 | €2.7b | 1.69% |
| 2026 | €2.8b | 3.10% |
| 2027 | €2.9b | 2.94% |
| 2028 | €3.0b | 3.86% |
| 2029 | €3.0b | 1.07% |
| 2030 | €3.0b | 3.01% |
| 2031 | €3.1b | 2.99% |
| 2032 | €3.2b | 3.00% |
8 Analysts have issued an Lenzing EBITDA forecast 2025. The average Lenzing EBITDA estimate is €449m . This is 10.35% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €484m 3.45% , the lowest is €401m 20.06% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | €121m | 32.20% |
|---|---|---|
| 2025 | €449m | 271.96% |
| 2026 | €509m | 13.25% |
| 2027 | €526m | 3.29% |
| 2028 | €574m | 9.12% |
EBITDA Margin
| 2024 | 4.54% | 25.11% |
|---|---|---|
| 2025 | 16.59% | 265.72% |
| 2026 | 18.23% | 9.89% |
| 2027 | 18.29% | 0.33% |
| 2028 | 19.22% | 5.08% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share € | -4.06 | 0.04 |
| 79.72% | 100.99% | |
| P/E | 605.53 | |
| EV/Sales | 0.97 |
7 Analysts have issued a Lenzing forecast for earnings per share. The average Lenzing EPS is €0.04 . This is 101.28% higher than earnings per share in the financial year 2024. The highest EPS forecast is €3.49 211.86% , the lowest is €-1.72 44.87% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | €-4.06 | 79.72% |
|---|---|---|
| 2025 | €0.04 | 100.99% |
| 2026 | €2.21 | 5,425.00% |
| 2027 | €2.09 | 5.43% |
| 2028 | €2.24 | 7.18% |
P/E ratio
| Current | -8.49 | 350.09% |
|---|---|---|
| 2025 | 605.53 | 7,229.25% |
| 2026 | 11.98 | 98.02% |
| 2027 | 12.69 | 5.93% |
| 2028 | 11.85 | 6.62% |
Based on analysts' sales estimates for 2025, the Lenzing stock is valued at an EV/Sales of 0.97 and an P/S ratio of 0.37 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 0.98 | 5.77% |
|---|---|---|
| 2025 | 0.97 | 0.61% |
| 2026 | 0.94 | 3.01% |
| 2027 | 0.92 | 2.85% |
| 2028 | 0.88 | 3.73% |
| 2029 | 0.89 | 1.09% |
| 2030 | 0.87 | 2.92% |
| 2031 | 0.84 | 2.91% |
| 2032 | 0.82 | 2.91% |
P/S ratio
| Current | 0.37 | 18.27% |
|---|---|---|
| 2025 | 0.37 | 0.54% |
| 2026 | 0.36 | 3.00% |
| 2027 | 0.35 | 2.84% |
| 2028 | 0.33 | 3.71% |
| 2029 | 0.34 | 1.08% |
| 2030 | 0.33 | 2.95% |
| 2031 | 0.32 | 2.88% |
| 2032 | 0.31 | 2.91% |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
